Literature DB >> 29860487

Atrial flow regulator for failing Fontan circulation: an initial European experience.

Lucia Manuri1, Rita Emanuela Calaciura1, Andrea De Zorzi1, Lilia Oreto1, Massimiliano Raponi2, Anja Lehner3, Nikolaus Haas3, Salvatore Agati1.   

Abstract

Transcatheter creation or enlargement of an atrial septal defect has been used to promote adequate blood flow and mixing in some forms of congenital heart defects or as a relief valve in right or left atrial hypertension, resulting in better cardiac output and/or systemic saturation. We report a case of a 4-year-old male affected by complex congenital heart disease who was admitted for management of severe cyanosis following a staged pericardial fenestrated Fontan procedure. Transoesophageal echocardiogram showed a wide fenestration of 9 mm in size with a severely dilated pericardial Fontan system. To avoid a new surgical procedure and as part of a compassionate use programme, we decided to implant an atrial flow regulator device (4 mm in diameter) with percutaneous approach with the goal of reducing the right-to-left shunt and increasing the pulmonary flow. Preprocedural oxygen saturation was 75%, whereas after 2 months of follow-up, we observed a progressive increase of up to 95% with significant reduction in the pericardial Fontan system dimensions at echocardiography.

Entities:  

Mesh:

Year:  2018        PMID: 29860487     DOI: 10.1093/icvts/ivy165

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  1 in total

1.  Use of pulmonary vasodilators in Fontan patients: a useful strategy to improve functional status and delay transplantation?

Authors:  Astrid E Lammers; Tilman Humpl
Journal:  Pulm Circ       Date:  2018-08-20       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.